- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
- MMJ BioPharma is seeking FDA approval for its clinical trials, facing regulatory requirements under the Administrative Procedure Act and demands from DEA Administrator Cole.
MMJ International Holdings is pursuing pharmaceutical development under FDA oversight, with its activities framed by the Controlled Substances Act.
6 reports, 1 independent
Updated Jul 6
Gone quiet
Reached 6 outlets in its first 24 hours
- Reports
- 6
- Developments
- 1
- Repetition
- 83%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MMJ International Holdings is pursuing pharmaceutical development under FDA oversight, with its activities framed by the Controlled Substances Act.
Who's involved
What this event is mainly aboutKeep exploring
Part of
MMJ BioPharma is seeking FDA approval for its clinical trials, facing regulatory requirements under the Administrative Procedure Act and demands from DEA Administrator Cole. All 1 developmentsWithin A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.